QIAGEN today announced it has entered into a definitive agreement to fully acquire Parse Biosciences, a leading provider of scalable, instrument-free solutions for single-cell research. The ...

Qiagen (QGEN) announced it has entered into a definitive agreement to fully acquire Parse Biosciences, a provider of scalable, instrument-free ...

Key market opportunities in oncology clinical trials include personalized treatment demand, advancements in AI-driven ...

Hyderabad has appointed Prof U Deva Priyakumar as its new Dean of Research and Development, marking a leadership transition ...

Evaxion introduces EVX-04, a novel vaccine candidate targeting multiple non-conventional ERV tumor antigens, developed withour AI-Immunology™ ...

When Sean Fletcher walked into Sam Biswas' Medical and Molecular Sciences (MMSC) lab at the University of Delaware College of Health Sciences during the summer of his first year, he had no research or ...

Scientific knowledge is fundamentally built on data; yet, for too long, research datasets have remained siloed, poorly ...

A vaccine that tackles the bacteria that cause up to 200 million childhood infections every year could be possible, experts ...

PANoptosis, an emerging concept in immunology, refers to a form of programmed cell death that integrates various signaling ...

Through cutting-edge methods and advanced artificial intelligence analysis, UNC Charlotte researchers leading a ...

Spinal cord injury (SCI) remains a major unmet medical challenge, often resulting in permanent paralysis and disability with ...

Spinal cord injury (SCI) remains a major unmet medical challenge, often resulting in permanent paralysis and disability with ...